Our partner is a clinical-stage biotechnology company that is driven to develop treatments that give cancer patients more choices and the possibility of better outcomes, particularly patients with RAS pathway mutations.

This critical hire led the business development process for future partnership opportunities and managed current partnerships. They ensured cross functional alignment and accelerated decision-making to drive corporate performance and acted as the point-person for all internal and external communications related to the company’s partnerships.